Navigation Links
ChemAxon Major Software Release brings New Desktop, Web and Visualization Applications to Power Chemistry Decision Making
Date:5/28/2013

BUDAPEST and CAMBRIDGE, Massachusetts, May 28, 2013 /PRNewswire/ --

New version sets the standard in chemistry software for scientists and IT infrastructure

ChemAxon, a leader in chemistry software solutions and consulting services for life science research, announces Version 6 of their cheminformatics suite. This major software release introduces four new products: Marvin for JavaScript, Instant JChem Web Client, REST Web Services, and the Plexus project, a public beta of a web-based discovery application for bench scientists. In addition, Version 6 sees a raft of enhancements across the ChemAxon Marvin/JChem product suite improving user experience, computational performance and collaboration support, and enabling more effective chemistry data management.

Version 6 for scientists:

  • All GUIs are refreshed to simplify both the user experience and access to key chemistry functions
  • Marvin for JavaScript - new light-weight chemical editor for web pages which does not require Java
  • Plexus - new web-based application for medicinal and computational chemists, featuring dynamic data visualization
  • Improved integration with Microsoft Office

Version 6 for enterprise IT:

  • Instant JChem Web Client - enables Instant JChem data visualization forms to be easily made available and worked with as Web pages
  • New REST Web Services to complement existing SOA Web Services
  • New search features and indexing support for ISIS and ChemDraw Excel workbooks in JChem for SharePoint
  • Enhanced compound registration capabilities, including project-related data storage

"Research-based organizations need to support increasingly diverse and distributed R&D environments," commented Alex Drijver, CEO of ChemAxon. "The Version 6 release deepens our core chemistry and technical capabilities, and focuses on making that functionality more relevant to researchers' processes with improved usability and new collaboration and analysis interfaces."

ChemAxon software is adopted by a diverse customer base to support and accelerate the process from initial concept to new product candidate, minimizing IT overheads. The software suite offers robust, scalable and flexible chemistry information management that is easily aligned with organizations' business processes. ChemAxon's client base includes all of the top 15 global pharma companies, major chemical and agrochemistry companies, innovative biotechnology enterprises and academic research centres world-wide.

ChemAxon Version 6 will be launched at the European UGM, May 28-29th, Budapest, Hungary (see chemaxon.com/events/ugm-budapest-2013). ChemAxon presentations outlining new features will be made available in our library archive as they are presented. We will also be hosting a series of Webinars to cover major new features. Follow us on Twitter twitter.com/chemaxon for notifications.

About ChemAxon
ChemAxon is a leader in providing cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions that power modern cheminformatics and chemical communication. The company is privately owned with European headquarters in Budapest, US East Coast headquarters in Cambridge, MA, and sales and support offices in Europe, Japan and across North America.


'/>"/>
SOURCE ChemAxon
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. ChemAxon Provides Chemistry Informatics Platform for the European Lead Factory
2. ChemAxons Chemicalize.org Extends PubChem Database With Crowd-Sourced Chemistry From the Web
3. Pearson Adds ChemAxons Suite of Chemistry Tools to MasteringChemistry Products
4. The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments
5. mPhase Technologies, Inc. Commencing Discussions with Major European Drug Company for Drug Delivery System
6. ?The MedZilla.com Employment Report for April, 2013: Unemployment Rate Drops as Obama Announces Major Bio-Tech Research Initiative
7. Laser-like photons signal major step towards quantum Internet
8. No Majority in Favor of Banning Key Crop Protection Technology
9. Major grant to investigate limits of quantum theory
10. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
11. Greenphires ClinCard Technology Platform selected by Bavarian Nordic for Major Vaccine Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):